GlassScriptPhysician profile
Lisa Ferguson
NPI 1548669831
$11,109.94
in general payments reported to CMS, 2019-2025
36 companies · $2,724 in 2025
The $2,724 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $774 · 2022: $1,407 · 2023: $1,693 · 2024: $4,511 · 2025: $2,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,513 · Travel and Lodging: $3,286 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,512.75 |
| Travel and Lodging | $3,285.66 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,133.82 | 2024-2025 | Watchman, Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $1,906.39 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novo Nordisk INC | $789.77 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $736.57 | 2022-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbvie INC. | $695.95 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $613.12 | 2022-2024 | Farxiga, Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $540.64 | 2022-2025 | |
| Lilly USA, LLC | $388.05 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $386.72 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $256.53 | 2022-2025 | |
| Abbott Laboratories | $185.88 | 2023-2025 | Mitraclip, Cardiomems, Freestyle Libre 3 |
| Amgen INC. | $174.35 | 2022-2024 | Otezla, Repatha |
| Astellas Pharma US INC | $170.74 | 2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.41 | 2022-2025 | Jardiance, Ofev |
| Phathom Pharmaceuticals, INC. | $152.34 | 2024 | Voquezna |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.